🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Inserting a gene that has been created in the laboratory into a ...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2004-05
Trial ID
NCT00085462
This study is to investigate the safety and efficacy on TIL engineered with...
Status
Completed
Location
Shanghai Tenth People's Hospital
Start Date
2022-03-10
Trial ID
NCT05468307
Treatments Being Tested
This is a study to investigate the efficacy and safety of an infusion of IO...
Status
Recruiting
Location
The Angeles Clinic and Research Institute
Start Date
2022-07-20
Trial ID
NCT05361174
Treatments Being Tested
DELTA-2 is a phase 1 clinical trial to evaluate the safety, feasibility, an...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-08
Trial ID
NCT05393635
Treatments Being Tested
This study is an open exploratory clinical study to evaluate the safety, to...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-08
Trial ID
NCT05971576
Treatments Being Tested
This experiment will test the safety and effectiveness of a treatment for m...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1999-08
Trial ID
NCT00001832
This study is to investigate the safety and efficacy of tumor infiltrating ...
Status
Recruiting
Location
Tongren Hospital Shanghai Jiao Tong University School Of Medicine.
Start Date
2021-04-22
Trial ID
NCT04967833
Treatments Being Tested
Background: * The National Cancer Institute (NCI) Surgery Branch has devel...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2013-12-12
Trial ID
NCT01993719
This is a Phase 1, open label clinical trial of tumor-infiltrating lymphocy...
Status
Unknown
Location
the Fifth Medical Center of PLA
Start Date
2024-07-01
Trial ID
NCT06463522
Treatments Being Tested
Adoptive T cell therapy (ACT) with tumor infiltrating lymphocytes (TIL) has...
Status
Completed
Location
Center for Cancer Immune Therapy Dept. of Hematology/oncology
Start Date
2016-12
Trial ID
NCT02926053